Related Experiment Video
Updated: Feb 16, 2026

Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis
Published on: January 4, 2019
[Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin]
1Department of Pediatrics, Yokohama City University of Medicine.
Insights
Plasma exchange therapy (PE) effectively prevents coronary artery lesions in Kawasaki disease (KD) cases resistant to intravenous immunoglobulin (IVIG). Early PE treatment within 10 days of onset is recommended for optimal outcomes in pediatric patients.
Area of Science:
- Pediatric Cardiology
- Immunology
- Critical Care Medicine
Context:
- Kawasaki disease (KD) affects 600-800 Japanese children annually, with coronary artery lesions (CALs) being a significant complication.
- Intravenous immunoglobulin (IVIG) is the standard treatment, but some cases are refractory.
Purpose:
- To evaluate the efficacy and safety of plasma exchange therapy (PE) as an alternative treatment for KD cases refractory to IVIG.
- To determine if early intervention with PE can prevent CALs in high-risk KD patients.
Summary:
- Plasma exchange therapy (PE) was administered to approximately 130 refractory KD cases since 1995.
- Multivariate analysis showed PE significantly reduced the risk of CALs (odds ratio 0.052, p = 0.0012).
- PE was found to be a safe and effective prophylactic measure against CALs when initiated early.
Impact:
- PE is a viable, safe, and effective treatment option for preventing CALs in IVIG-refractory KD.
- Early initiation of PE (within 10 days of onset) is crucial for maximizing its prophylactic benefits.
- This study supports the integration of PE into treatment protocols for severe or refractory KD cases.
Abstract:
Kawasaki disease (KD) causes coronary artery lesions (CALs) in 600 to 800 Japanese children each year. As part of our recent search for effective treatments for KD cases refractory to intravenous immunoglobulin (IVIG), we have tried plasma exchange therapy (PE) in approximately 130 cases since 1995 till now. Multivariate analysis demonstrated that PE was effective approach for the prevention of CALs (odds ratio 0.052, p = 0.0012). We concluded that PE was a safe, effective prophylactic measure against CALs. Thus, PE should be performed at an early stage of this disease, by 10 days after onset, for KD cases refractory to IVIG.
More Related Videos
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Acute Kidney Injury V: Interprofessional Care
Continuous Renal Replacement Therapy
Myocarditis III: Medical Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

